Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
about
A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritisA candidate gene study of CLEC16A does not provide evidence of association with risk for anti-CCP-positive rheumatoid arthritisTRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide studyGenetic studies of rheumatoid arthritisRheumatoid arthritis susceptibility genes: An overviewAutoantibodies in systemic autoimmune diseases: specificity and pathogenicityA genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.Gene hunting of the Genetic Analysis Workshop 16 rheumatoid arthritis data using rough set theory.A principal-components-based clustering method to identify multiple variants associated with rheumatoid arthritis and arthritis-related autoantibodies.A Bayesian latent class analysis for whole-genome association analyses: an illustration using the GAW15 simulated rheumatoid arthritis dense scan dataData for Genetic Analysis Workshop (GAW) 15 Problem 2, genetic causes of rheumatoid arthritis and associated traitsA case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity.The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.Comparison of methods for correcting population stratification in a genome-wide association study of rheumatoid arthritis: principal-component analysis versus multidimensional scaling.Data for Genetic Analysis Workshop 16 Problem 1, association analysis of rheumatoid arthritis dataIdentification of correlated genetic variants jointly associated with rheumatoid arthritis using ridge regressionAutoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodiesDifferent patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region.Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factorAssociations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritisAnti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.Genetic basis of autoantibody positive and negative rheumatoid arthritis risk in a multi-ethnic cohort derived from electronic health records.Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritisRobust methods for population stratification in genome wide association studiesSeveral regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locusThe chromosome 7q region association with rheumatoid arthritis in females in a British population is not replicated in a North American case-control series.Anti-citrullinated peptide/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a meta-analysis of genome-wide association study in a Japanese population.Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis.Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritisInteractions between amino acid-defined major histocompatibility complex class II variants and smoking in seropositive rheumatoid arthritis.Pharmacogenetics of rheumatoid arthritis: Potential targets from susceptibility genes and present therapies.A study on FoxP3 and Tregs in paired samples of peripheral blood and synovium in rheumatoid arthritis.Genetics of autoimmune diseases--disorders of immune homeostasis.Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients.Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking.Identification of the NF-κB activating protein-like locus as a risk locus for rheumatoid arthritis.STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus.Anti-CCP2 antibodies: an overview and perspective of the diagnostic abilities of this serological marker for early rheumatoid arthritis.
P2860
Q24609382-8146CE2C-2146-42AB-9AAB-B9578E8FA449Q24634112-1E91C3C5-BEDE-463D-BFD1-73AA4072E7AFQ24657292-DEF68845-9EEE-4929-A1A7-81C2568E64AAQ26783892-60AD2F80-61D7-4E17-A366-812EAAB8F2F4Q26824670-86DADEB6-D6C4-4584-8A40-5C8A41A2BDC4Q27024588-7E232FAC-AEE7-49A4-81AF-3B4E60E75BF3Q29417158-764515A6-FA0C-4573-804C-5ED5A4BF92D4Q30975940-1E21AE2D-81F8-46AB-AB3A-D98AA8974F2DQ30975971-938CCCD1-5AE0-418D-A986-C70CC458FAC6Q31154835-8F1E9BCB-BEB5-4752-88B3-5546DFBFE537Q31154891-FB536242-221A-45B2-993B-094576020C48Q33300467-90D299B2-F267-4CF9-99D0-58A6DDC63033Q33332641-F9B201EA-DE9D-44DE-8773-450E33773122Q33519221-E597463A-B162-4F6E-B2D5-8D7152E0C795Q33519271-D3FAA3A7-D5C8-4CA0-A0F3-B7D5705F94C2Q33519359-9AEE594B-2178-4E22-9D18-BD2455ACD639Q33673310-6974600B-6E4B-4E70-84FD-B5CCA231FF49Q33868008-19D49532-369B-45A4-8B7E-313BA9CE0218Q33923415-02C8AF77-7E3D-4093-A7B6-7388587A6BACQ34156559-905118DA-734C-4CE5-BAE1-1B025D0E1BAEQ34310761-1277D2D1-E990-4AB2-AB3D-1E95C89469CCQ34367709-384A6DD5-E646-44D5-9FEF-71A19C5B03B0Q34458840-8A16EBEF-CC05-446F-9DC7-5A26F624F6BEQ34616781-54DE299A-F6A7-4B6E-AE7D-0047BEAC3535Q34677850-6A0CF68F-E27D-4B32-8DA5-2C422B561D72Q34756777-F979C4E6-BDD3-4577-BB48-8168CB92E311Q34912912-A722E41C-CD5F-4215-82BA-B57EB31CB701Q35605019-5FCA765B-E8AA-4B98-BB52-E9BAE4E4DED2Q35605524-DE0FF84F-C4FA-4565-BA13-60350A8F4DCDQ35645491-3EA5BA1A-2C22-4F61-9BFA-187FFB260C85Q35868959-3943A4A9-4618-4CA7-80DF-D2EFC12CC889Q36090224-43F21E5F-394D-4BD4-AF2F-6B27852C73CEQ36441438-244FCF0C-B71F-4613-AFF8-9034989F2B48Q36534242-8D569B79-ABBC-4099-9438-DCF8E46EDB18Q36670483-BA53CFDA-77AE-4FBC-A0DD-D1D8CEA38E37Q36679775-C55000D4-497C-4B97-BA69-F9033A4951C5Q36790341-A00E4AD9-B699-4687-9D14-9D14269D7266Q36939437-58F48019-2057-49D8-85E1-C8995601BD48Q37070948-80D1D74B-3568-407C-BD55-5BB204B49BFEQ37083382-11F4857A-2C6F-4BB2-A263-D4C85C69490F
P2860
Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Regulation of anti-cyclic citr ...... nd the shared epitope alleles.
@en
Regulation of anti-cyclic citr ...... nd the shared epitope alleles.
@nl
type
label
Regulation of anti-cyclic citr ...... nd the shared epitope alleles.
@en
Regulation of anti-cyclic citr ...... nd the shared epitope alleles.
@nl
prefLabel
Regulation of anti-cyclic citr ...... nd the shared epitope alleles.
@en
Regulation of anti-cyclic citr ...... nd the shared epitope alleles.
@nl
P2093
P50
P356
P1476
Regulation of anti-cyclic citr ...... nd the shared epitope alleles.
@en
P2093
Annette T Lee
Claire Bombardier
Daniel L Kastner
Elena Massarotti
Franak Batliwalla
Lindsey A Criswell
Mark H Wener
Marlena Kern
Michael F Seldin
Michael Weisman
P304
P356
10.1002/ART.21419
P577
2005-12-01T00:00:00Z